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Identity 




5360 base-pairs DNA linear, starts at 3064713 and ends
at 3070072 bp from pter with minus strand orientation. 
This gene contains 2 exons. 
Transcription 
The transcription produces 2 alternatively spliced 
mRNA variants: 
- NM_021195.4: transcript length: 2139 bp, 
- ENST00000396925: transcript length: 1739 bp. 
Pseudogene 
Pseudogene of claudin 6 (LOC284620) is located on 
chromosome 1 (859 bp). 
Protein 
Description 
The transcription of this gene gives 1 spliced mRNA 
that encodes 1 protein isoform with 220 aa and 2329 
Da of molecular weight. 
Expression 
Claudin-6 expression is mainly found in mouse 
embryonic stem cells (ESC), epithelial lineage cells 
during early development and primitive germ cell 
tumours such as spermatocytic seminoma, embryonal 
carcinoma, yolk sac tumour, choriocarcinoma, 
immature teratoma, mature teratoma and classic 
seminoma. Its expression is very weak or absent in 
adult mouse. In rat choroid plexus development 
claudin-6 is expressed postnatal between day 6 and 9. 
Claudin-6 expression is associated to ERα expression 
in human breast cancer and is inactivated by CpG 
island DNA hypermethylation. 
 
 










This transmembrane protein is located in the tight 
junction during embryogenesis and, in certain cancer 
pathologies.  
It can be found in the cell cytoplasm and in the nucle s. 
Function 
Claudin-6 regulates chloride and sodium permeability, 
and increases transepithelial electrical resistance i  
MDCK cells.  
It also has a Ca2+ independent cell adhesion activity.  
Is one of the entry cofactors for hepatitis C virus.  
Claudin-6 gene methylation may be involved in 
esophageal tumorogenesis. 
Homology 
The CLDN6 gene sequence is conserved in human, 




A heterozygous substitution (p.T33T) in position 33 in 
ovarian serous carcinoma, and an homozygous 
substitution (p.T33T) in position 135 in stomach 
adenocarcinoma, have been reported. 
 










Up-regulation of claudin-6 expression in MCF-7 cells 
suppressed their malignant phenotype and restored tight 
junction integrity. Claudin-6 down-regulation 
contributes to the malignant progression of certain 
types of breast cancers.  
Claudin-6 mRNA was low or undetectable in two rat 
mammary cancer cell lines, two human breast cancer 
cell lines, and one breast cancer sample compared to 
normal breast tissue (Quan and Lu, 2003). Decreased 
expression of claudin-6 promotes cellular invasiveness, 
transendothelial migration and an increase in matrix 
metalloproteinase activity (Osanai et al., 2007). The 
methylated phenotype of claudin-6 contributes to 
enhanced tumorigenic and invasive properties of breast 
carcinoma cells. Claudin-6 may function as tumor 
suppressor, particularly for breast cancer. 
Gastric adenocarcinoma 
Note 
Abnormal claudin expression has been documented in 
several malignancies. Strong claudin-6 expression was
associated with higher mortality rate in the diffuse- vs 
the intestinal-type gastric adenocarcinoma after a 2-
year follow-up (Rendón-Huerta et al., 2010). Claudin-6 
expression is closely related to gastric carcinogenesis, 
and their detection is a useful prognostic marker in 
gastric adenocarcinoma.  
Claudin-6 overexpression in AGS cells enhanced their 
invasive potential (1,6-fold), cell migration and 
proliferation rate (13,3%); it also increased claudin-1 
and zonula occludens-1 levels (Zavala-Zendejas et al., 
2011). Increased expression of claudin-6 is sufficient to 
enhance tumorigenic properties of a gastric 
adenocarcinoma cell line. 
Brain tumors 
Note 
Claudin-6 is a positive marker for atypical 
teratoid/rhabdoid tumors (AT/RTs) (Birks et al., 2010). 
AT/RTs are highly aggressive pediatric brain tumors. 
CLDN6 showed moderate or higher mRNA expression 
in eight of nine AT/RTs, with little to no expression in 
114 of 115 other tumors. CLDN6 may be a useful 
marker to identify atypical teratoid/rhabdoid tumors 
AT/RTs. 
Hepatitis C virus infection 
Note 
Claudin-6 mediates the entry of HCV into target cells. 
Claudin-6 is expressed in the liver, the primary site of 
HCV replication. Claudin-6 expressed in CD81+ 
(tetraspanin) cells enables the entry of HCV 
pseudoparticles. Claudin-1 and -6 function equally well 
as entry cofactors in endothelial cells but claudin-1 is 
more efficient in hepatoma cells (Meertens et al., 
2008). This suggests that additional cellular factors 




Epigenetic regulators such as TSA, 5-aza, and DMSO 
significantly enhance the expression of claudin-9 in 
corneal cells, changing transcriptional signals by 
demethylating CpG islands (Nishikiori et al., 2008); 
additionally, the epigenetic regulators increase 
transendothelial electrical resistance and suppress 
fluxes of corneal cells, thus enhancing the corneal 




Claudin-6 mRNA is differentially expressed in four 
different adipose tissues, and up regulated in each f t 
depot of mice fed a high-fat diet as compared to a 
normal-fat diet. Levels of claudin-6 transcripts were 
increased during differentiation of 3T3-L1 cells in vitro 
but small interfering RNA-mediated reduction of 
claudin-6 mRNA inhibited its differentiation (Hong et
al., 2005). Claudin-6 is an important regulator of 
adipogenesis and fat deposition. 
Neonatal development 
Note 
Claudin-6 is a global marker of definitive endoderm 
and the development of the pancreas, lung and liver; 
CLDN6 null mice are viable and with no obvious 
phenotypic abnormalities (Anderson et al., 2008). 
Homozygous mice overexpressing claudin-6 exhibit a 
perturbation in the epidermal differentiation program 
leading to a defective epidermal permeability barrier 
(EPB); Inv-Cldn6 transgenic animals die within 2 days 
of birth, due to the lack of an intact EPB, inversely 
heterozygous Inv-Cldn6 mice exhibit a distinct coat 
phenotype and mild epidermal hyperkeratosis (Troy et 
al., 2005).  
A defective EPB has been shown in premature birth 
neonates (Turksen and Troy, 2002). Claudin 6 has a 
major role in epithelial differentiation and EPB 
assembly/maintenance.  
Claudin-6 expression is fundamental for the formation 
of the trophectoderm (TE), the first epithelium 
generated during mammalian early development that 
isolates the inner cell mass from the uterine 
environment and provides the turgidity of the 
blastocyst through elevated hydrostatic pressure 
(Moriwaki et al., 2007). Claudin-6 was absent from TE 
tight junctions, and thus the barrier function of the TE 
was disrupted, when embryos were cultured in the 
presence of Clostridium perfringens enterotoxin.  
Claudin-6 expression in the neonatal proximal tubule 
result in an increased transepithelial resistance, 
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decreased chloride permeability, and decreased 
P(Na)/P(Cl) and P(HCO3)/P(Cl) (Sas et al., 2008). 
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